Liou JS et al. |
Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. |
2000 |
J. Biol. Chem. |
pmid:10967125
|
Mariadason JM et al. |
Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. |
2000 |
Cancer Res. |
pmid:10969808
|
Hobbs CA and Gilmour SK |
High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. |
2000 |
J. Cell. Biochem. |
pmid:10760944
|
Yoshida M and Horinouchi S |
[Histone deacetylase inhibitors--new anticancer agents?]. |
2000 |
Tanpakushitsu Kakusan Koso |
pmid:10771678
|
Yu F et al. |
Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. |
2000 |
Nucleic Acids Res. |
pmid:10773092
|
Kitamura K et al. |
Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid. |
2000 |
Br. J. Haematol. |
pmid:10792271
|
Saleh M et al. |
Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. |
2000 |
Mol. Cell. Biol. |
pmid:11046157
|
Diamond SE and Gutierrez-Hartmann A |
The Pit-1beta domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter. |
2000 |
J. Biol. Chem. |
pmid:10921928
|
Andoh A et al. |
Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells. |
2000 |
Int. J. Mol. Med. |
pmid:10851266
|
Siavoshian S et al. |
Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. |
2000 |
Gut |
pmid:10716680
|
Gray SG et al. |
IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a. |
2000 |
Cytokine |
pmid:10880258
|
Su GH et al. |
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. |
2000 |
Cancer Res. |
pmid:10866300
|
Lin F et al. |
Unique anti-activator protein-1 activity of retinoic acid receptor beta. |
2000 |
Cancer Res. |
pmid:10866321
|
Hemavathy K et al. |
Human Slug is a repressor that localizes to sites of active transcription. |
2000 |
Mol. Cell. Biol. |
pmid:10866665
|
Jin S et al. |
Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. |
2000 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10841572
|
Claassen GF and Hann SR |
A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. |
2000 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10920185
|
DiRenzo J et al. |
BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. |
2000 |
Mol. Cell. Biol. |
pmid:11003650
|
Hu JF et al. |
Allele-specific histone acetylation accompanies genomic imprinting of the insulin-like growth factor II receptor gene. |
2000 |
Endocrinology |
pmid:11108251
|
Nakayama T et al. |
Epigenetic regulation of androgen receptor gene expression in human prostate cancers. |
2000 |
Lab. Invest. |
pmid:11140692
|
Pender SL et al. |
Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells. |
2000 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:11052988
|